Tricaprilin (CER-0001) for the preventive treatment of migraine: A phase 2 randomised, double-blind, placebo-controlled pilot study.

tricaprilin (AC-1204) - Cerecin

http://www.ncbi.nlm.nih.gov/pubmed/39094432

Elspeth Hutton; Julia Presanis; Lilian Chow; Marc Cantillon; Mark Bloch; Nikki McIntyre; Samuel Henderson

Aug 3, 2024